Home/Filings/4/0001104659-22-002844
4//SEC Filing

Branning Todd P. 4

Accession 0001104659-22-002844

CIK 0001173281other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 7:19 PM ET

Size

6.0 KB

Accession

0001104659-22-002844

Insider Transaction Report

Form 4
Period: 2022-01-10
Branning Todd P.
Chief Financial Officer
Transactions
  • Award

    Employee stock option (right to buy)

    2022-01-10+300,000300,000 total
    Exercise: $2.52Exp: 2032-01-10Common stock (300,000 underlying)
Footnotes (1)
  • [F1]1/4th of the total shares shall vest on the first anniversary of the effective date of employment, and 1/36th of the remaining shares shall vest on a monthly basis starting on the first anniversary of the effective date of employment; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive.

Issuer

NeuBase Therapeutics, Inc.

CIK 0001173281

Entity typeother

Related Parties

1
  • filerCIK 0001765274

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 7:19 PM ET
Size
6.0 KB